Galera Therapeutics Q4 2023 GAAP EPS Analysis
Thursday, 28 March 2024, 18:58
Galera Therapeutics Q4 2023 Financial Results
Galera Therapeutics recently reported its Q4 2023 GAAP EPS of -$0.10. The company's financial standing includes holding $18.3 million in cash and cash equivalents as of December 31, 2023.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.